Press Coverage

Wuxi Biologics’ Non-Covid Revenue a Key Focus: Preview

Excerpt:“…operations soon, may fuel its expansion in Europe this year CMB International (via SMARTKARMA) Non-Covid revenue may have grown by about 68% y/y in 2022 The…”

BFW (Bloomberg First Word)via Bloomberg • (Opens in a new window) ⧉

Are you a Professional Journalist?

The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.


Request your Press Pass Now

BFW (Bloomberg First Word)